108737 ⎘
Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor; Animal cells or tissues; Human cells or tissues; Vertebrate cells; Embryonic cells ; Embryoid bodies Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
METHOD OF INDUCING OR IMPROVING WOUND HEALING PROPERTIES OF MESENCHYMAL STEM CELLS
#2METHOD OF REPAIRING CARTILAGE DAMAGE
#3IMMUNOCOMPATIBLE CHORIONIC MEMBRANE PRODUCTS
#4ACELLULAR PLACENTAL PREPARATIONS
#5Scalable Expansion of CD71+ Erythroid Progenitor Cells for Cell Therapy
#6CLINICAL DERIVATIONS OF AN ALLOGENIC CELL AND THERAPEUTIC USES
#7COMPOSITION COMPRISING AMNIOTIC FLUID STEM CELLS OR DERIVATIVES THEREOF AND USE THEREOF
#8DECELLULARIZED AMNIOTIC MEMBRANE MATRIX HYDROGEL AND METHOD OF PREPARATION THEREOF
#9METHODS AND COMPOSITIONS FOR THE CLINICAL DERIVATION OF A STEM CELL AND THERAPEUTIC USES
#10MIXTURES OF PLACENTAL PARTICLES, GRAFTS INCLUDING THEM, AND METHODS FOR MAKING AND USING THEM
#11PLACENTA ORGANOID ON-A-CHIP AND USE THEREOF
#12Producer Cell Having Low Levels of VA-RNA
#13METHODS OF MANUFACTURE OF THERAPEUTIC PRODUCTS COMPRISING VITALIZED PLACENTAL DISPERSIONS
#14EXTRACELLULAR VESICLES ISOLATED FROM STEM CELLS, AND USES THEREOF
#15EXOSOME SYSTEMS, PRODUCTS AND METHODS
#16EXOSOME SYSTEMS, PRODUCTS AND METHODS
#17Human Homogeneous Amniotic Fluid Stem Cell Lines And Uses Thereof
#18SYSTEMS AND METHODS TO DETECT STEM CELL STRESS AND USES THEREOF
#19METHOD FOR ENHANCING EXPRESSION OF INSULIN LIKE GROWTH FACTOR 1 RECEPTOR IN UMBILICAL CORD MESENCHYMAL STEM CELL AND METHOD FOR OBTAINING MULTIPOTENT UMBILICAL CORD MESENCHYMAL STEM CELL
#20COMPOSITIONS AND METHODS FOR CULTURING AND MAINTAINING TROPHOBLAST STEM CELLS
#21Compositions Derived from Placenta and Methods of Producing the Same
#22FLOWABLE BIRTH TISSUE COMPOSITION AND RELATED METHODS
#23METHOD AND MATERIAL FOR DIFFERENTIATED SEQUESTRATION OF SUBSTANCES OF DIFFERENT SUBSTANCE GROUPS WITH THE AID OF HYDROGELS CONTAINING SULPHATED OR SULPHONATED COMPONENTS
#24METHOD AND MATERIAL FOR DIFFERENTIATED SEQUESTRATION OF SUBSTANCES OF DIFFERENT SUBSTANCE GROUPS WITH THE AID OF HYDROGELS CONTAINING SULPHATED OR SULPHONATED COMPONENTS
#25METHODS OF MANUFACTURE OF IMMUNOCOMPATIBLE CHORIONIC MEMBRANE PRODUCTS
#26POURABLE PLACENTAL COLLAGEN MATRIX SHEET
#27USE OF CD90+ HUMAN AMNIOTIC EPITHELIAL CELLS IN TREATMENT OF GRAFT VERSUS HOST DISEASE
#28CELL REPAIR-PROMOTING EXTRACELLULAR VESICLE, PRODUCTION METHOD, PREPARATION, AND USE THEREOF
#29USE OF SECRETOME OF AMNIOTIC FLUID STEM CELL IN THE TREATMENT OF DRY EYE DISEASE
#30MITOCHONDRIAL AUGMENTATION THERAPY WITH STEM CELLS ENRICHED WITH FUNCTIONAL MITOCHONDRIA
#31PRECURSORY REGULATORY CYTOTROPHOBLAST CELLS AND USES THEREOF
#32CELL POPULATION AND CELL POPULATION PRODUCTION METHOD
#33EMBRYONIC CELL CULTURES AND METHODS OF USING THE SAME
#34HUMAN TROPHOBLAST STEM CELLS AND USES THEREOF
#35PLACENTAL MESENCHYMAL STEM CELLS, METHODS OF PRODUCTION, AND PLACENTAL MESENCHYMAL STEM CELL BASED THERAPEUTICS
#36Composition and Method for Treating Diseases Thereof
#37PLACENTAL CELL TREATMENT FOR CRITICAL LIMB ISCHEMIA PATIENT SUBPOPULATIONS
#38THERAPEUTIC PRODUCTS COMPRISING VITALIZED PLACENTAL DISPERSIONS
#39COMPOSITIONS OF FUNCTIONAL MITOCHONDRIA AND USES THEREOF
#40TRANSCRIPTION FACTORS CONTROLLING DIFFERENTIATION OF STEM CELLS
#41IMMUNOCOMPATIBLE AMNIOTIC MEMBRANE PRODUCTS
#42IMMUNOCOMPATIBLE AMNIOTIC MEMBRANE PRODUCTS
#43EXOSOME SYSTEMS, PRODUCTS AND METHODS
#44CELL CLUSTER PRODUCTION METHOD
#45EQUINE-SPECIFIC THERAPEUTIC COMPOSITIONS AND METHODS OF USE
#46VENTED WOUND DRESSING BARRIER
#47METHOD FOR REPROGRAMMING HUMAN CELLS
#48GENERATION OF NEURAL STEM CELLS FROM HUMAN TROPHOBLAST STEM CELLS
#49BIOMARKERS ON CELLULAR ENDOCRINE MODELS FOR ENDOCRINE DISRUPTION ASSESSMENT
#50IDENTIFICATION OF MITOCHONDRIA-ENRICHED CELLS
#51SECRETOME FRACTIONS AND USES THEREOF
#52Methods of manufacture of therapeutic products comprising vitalized placental dispersions
#53METHOD FOR MASS PRODUCTION OF HIGHLY PURE, STEM CELL-DERIVED EXTRACELLULAR VESICLE BY USING PEPTIDE
#54STEM CELL AND TISSUE CULTURES AND THEIR PRODUCTS
#55Regenerative Tissue Extract from Non-Human Mammalian Placenta
#56DEVELOPMENT OF AMNION-LIKE TISSUE FROM HUMAN PLURIPOTENT STEM CELLS
#57Methods of manufacture of immunocompatible chorionic membrane products
#58DERIVATION OF TROPHOBLAST ORGANOIDS FROM NAIVE HUMAN PLURIPOTENT STEM CELLS
#59Methods and Compositions for Generating Human Forebrain Neural Progenitor Cells and for Maturation Thereof to Parvalbumin+ Interneurons
#60Methods of Genomic Evaluation in Livestock
#61TROPHOBLAST STEM CELL-LIKE CELLS CAPABLE OF DIFFERENTIATING INTO PLACENTA-CONSTITUTING CELLS, AND METHOD FOR PRODUCING SAME
#62UMBILICAL CORD PRODUCTS
#63CULTIVATION OF PLACENTA TO ISOLATE EXOSOMES
#64TREATMENT OF LYMPHEDEMA AND RELATED CONDITIONS USING PLACENTAL ADHERENT CELLS
#65THERAPEUTIC REGENERATIVE CELLS
#66ARTIFICIAL PLACENTA VACCINE FOR ORGAN TRANSPLANTATION
#67FETAL TROPHOBLAST COMPOSITIONS AND METHODS
#68PLACENTA-DERIVED MATRIX AND METHODS OF PREPARING AND USE THEREOF
#69CRANIAL NERVE DISORDER THERAPEUTIC AGENT INCLUDING CULTURE SUPERNATANT OF TISSUE CELLS DERIVED FROM FETAL APPENDAGE
#70CRANIAL NEUROPATHY THERAPEUTIC AGENT CONTAINING CULTURE SUPERNATANT FOR UMBILICAL CORD BLOOD MONOCYTIC CELLS
#71AMNIOTIC-LIKE EPITHELIAL CELL GENERATION
#72Method for isolating placental trophoblast cells from cervical exfoliated cells of pregnant woman
#73UMBILICAL CORD DERIVED REGENERATIVE AND IMMUNE MODULATORY STEM CELL POPULATIONS
#74LARGE-SCALE PRODUCTION OF EXOSOMES FROM PRIMED MESENCHYMAL STROMAL CELLS FOR CLINICAL USE
#75DIFFERENTIATION OF TROPHECTODERM LINEAGE CELLS FROM PLURIPOTENT STEM CELLS
#76COMPOSITIONS AND METHODS FOR PRODUCING PLACENTAL CELLS
#77Vented wound dressing barrier
#78USE OF MITOCHONDRIA TO TREAT AND/OR PREVENT TENDON INJURY OR ITS RELATED DISEASE
#79PLACENTA-DERIVED MULTIPOTENT STEM CELLS
#80Pharmaceutical composition comprising stem cell-conditioned medium and exosome isolated therefrom as active ingredient for prevention or treatment of ocular disease
#81METHODS OF MANUFACTURE OF IMMUNOCOMPATIBLE AMNIOTIC MEMBRANE PRODUCTS
#82Products Derived from Amniotic Fluid and Methods of Use
#83REGENERATIVE NONSTEROIDAL ANTI-INFLAMMATORY COMPOSITIONS, METHODS OF PRODUCTION, AND METHODS OF USE THEREOF
#84Method for inhibiting growth of cancer cells using anti-cancer composition with mesenchymal stem cells conditioned medium
#85IMMUNOCOMPATIBLE CHORIONIC MEMBRANE PRODUCTS
#86SUPPORTING BATH FOR THREE-DIMENSIONAL (3D) TISSUE CULTURE
#87Compositions Derived from Placenta and Methods of Producing the Same
#88PHARMACEUTICAL COMPOSITION CONTAINING NEPRILYSIN-OVEREXPRESSING STEM CELL, CONDITIONED MEDIUM THEREOF, AND EXOSOME ISOLATED THEREFROM AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF COGNITIVE IMPAIRMENT
#89STEM CELL COMPOSITIONS AND METHODS OF PRODUCING STEM CELLS FOR THERAPEUTIC APPLICATIONS
#90ENHANCED PLACENTAL STEM CELLS AND USES THEREOF
#91Method and composition for hypothermic storage of placental tissue
#92ENHANCEMENT OF UMBILICAL CORD MESENCHYMAL STEM CELL THERAPEUTIC ACTIVITY BY STIMULATORS OF T REGULATORY CELLS AND/OR CELLS EXPRESSING CD73
#93Method for enhancing expression of insulin like growth factor 1 receptor in umbilical cord mesenchymal stem cell expressing IGF1R and method for obtaining multipotent umbilical cord mesenchymal stem cell
#94USE OF A CELL CULTURE COMPOSITION FOR PROMOTING CELL GROWTH
#95VIRAL INACTIVATION METHOD, METHOD FOR PRODUCING DRIED AMNION, AND DRIED AMNION
#96Methods for Reprogramming Cells
#97USE OF SECRETOME OF AMNIOTIC FLUID STEM CELL IN THE TREATMENT OF DRY EYE DISEASE
#98CELL POPULATION COMPRISING MESENCHYMAL STEM CELLS DERIVED FROM FETAL APPENDAGE, METHOD FOR PRODUCING THE SAME, AND PHARMACEUTICAL COMPOSITION
#99Compositions Derived from Placenta and Methods of Producing the Same
#100Stem Cells Derived from Villi Adjacent to Chorionic Plate, and Tissue Regeneration Cellular Therapeutic Agent Comprising Same
#101COMPOSITIONS CONTAINING AMNIOTIC COMPONENTS AND METHODS FOR PREPARATION AND USE THEREOF
#102COMPOSITIONS DERIVED FROM HUMAN AMNION CELLS & RELATED METHODS
#103PERIVASCULAR LYSATES AND USES THEREOF
#104STEM CELL LINE FOR TREATMENT OF VARIOUS MEDICAL CONDITIONS
#105Generation of neural stem cells from human trophoblast stem cells
#106CELLS CAPABLE OF DIFFERENTIATING INTO PLACENTA-CONSTITUTING CELLS, AND METHOD FOR PRODUCING SAME
#107METHODS AND COMPOSITIONS FOR THE CLINICAL DERIVATION OF A STEM CELL AND THERAPEUTIC USES
#108METHODS AND COMPOSITIONS FOR THE CLINICAL DERIVATION OF A STEM CELL AND THERAPEUTIC USES
#109METHODS AND COMPOSITIONS FOR THE CLINICAL DERIVATION OF A STEM CELL AND THERAPEUTIC USES
#110PLACENTA-DERIVED ADHERENT CELL EXOSOMES AND USES THEREOF
#111BONE MARROW MICROGLIA PROGENITOR CELLS AND USES THEREOF
#112Artificial Placenta And Methods Of Preparation
#113TREATMENT OF DIABETES USING IMMUNE CELLS REPROGRAMMED EX VIVO BY REGENERATIVE CELLS
#114Exosome systems, products and methods
#115Three-Dimensional Cross-Linked Scaffolds of Cord Blood Plasma and Their Use
#116METHODS OF TISSUE PROCESSING
#117USE OF ADHERENT STROMAL CELLS FOR ENHANCING HEMATOPOIESIS IN A SUBJECT IN NEED THEREOF
#118METHODS FOR ENRICHING POPULATIONS OF CELLS
#119Method for constructing functional exosomes capable of efficiently loading specific miRNA
#120METHOD OF HARVESTING MESENCHYMAL STEM CELLS FROM CORD-PLACENTA JUNCTION
#121TROPHOBLAST STEM CELL, METHODS OF PREPARATION AND USES THEREOF
#122YAP1 Gene-Modified Mesenchymal Stem Cell and Preparation Method Thereof
#123METHOD OF PRODUCING PLACENTA-LIKE ORGANOID, PLACENTA-LIKE ORGANOID, AND PRODUCTION OR TEST KIT
#124COMPOSITIONS DERIVED FROM HUMAN AMNION CELLS & RELATED METHODS
#125METHODS FOR CULTURING MESENCHYMAL STEM CELLS, PRODUCTS THEREOF, AND APPLICATIONS THEREOF
#126PLACENTA-DERIVED ALLOGENEIC CAR-T CELLS AND USES THEREOF
#127USE OF NEUROPILIN-1 (NRP1) AS A CELL SURFACE MARKER FOR ISOLATING HUMAN CARDIAC VENTRICULAR PROGENITOR CELLS
#128TISSUE-DERIVED TISSUEGENIC IMPLANTS, AND METHODS OF FABRICATING AND USING SAME
#129METHODS AND COMPOSITIONS FOR TREATMENT OF BONE DEFECTS WITH PLACENTAL CELL POPULATIONS
#130Methods and Compositions for the Clinical Derivation of an Allogenic Cell and Therapeutic Uses
#131Cell Expression System
#132HANDLING OF MEMBRANE-SHAPED TISSUE
#133IMMUNOCOMPATIBLE AMNIOTIC MEMBRANE PRODUCTS
#134Precursory regulatory cytotrophoblast cells and uses thereof
#135METHODS AND COMPOSITIONS FOR TREATING SUBJECTS EXPOSED TO VESICANTS AND OTHER CHEMICAL AGENTS
#136ISOLATION AND CULTIVATION OF STEM/PROGENITOR CELLS FROM THE AMNIOTIC MEMBRANE OF UMBILICAL CORD AND USES OF CELLS DIFFERENTIATED THEREFROM
#137MITOCHONDRIAL AUGMENTATION THERAPY WITH STEM CELLS ENRICHED WITH FUNCTIONAL MITOCHONDRIA
#138SYSTEMS AND METHODS FOR 3D PRINTING OF PROTEINS
#139COMPOSITIONS AND METHODS UTILIZING AMNIOTIC FLUID STEM CELLS
#140METHOD OF INDUCING OR IMPROVING WOUND HEALING PROPERTIES OF MESENCHYMAL STEM CELLS
#141Cell culture method and automatic cell culture apparatus
#142METHODS AND COMPOSITIONS FOR TREATING VIRAL INFECTIONS
#143ISOLATION OF CIRCULATING CELLS OF FETAL ORIGIN USING RECOMBINANT MALARIA PROTEIN VAR2CSA
#144Human trophoblast stem cells and uses thereof
#145NEONATAL STROMAL CELLS HAVING LOW MHC-I EXPRESSION AND USES THEROF
#146Flowable birth tissue composition and related methods
#147Flowable birth tissue composition and related methods
#148METHODS OF CANCER IMMUNOTHERAPY
#149Use of cells derived from first trimester umbilical cord tissue
#150Method Of Processing Amnion To Form A Suture
#151Enhanced placental stem cells and uses thereof
#152In vitro production of expanded potential stem cells
#153ANGIOGENESIS USING STIMULATED PLACENTAL STEM CELLS
#154THERAPEUTIC DOSAGE REGIMENS COMPRISING ADHERENT STROMAL CELLS
#155GENERATION OF HUMAN ENDODERMAL ORGANS IN PIG MODEL USING LINEAGE RESTRICTED ENDODERMAL PRECURSORS
#156Embryonic cell cultures and methods of using the same
#157Cell line consecutively expressing HLA-G protein and method for preparing the same
#158Methods for treating cardiac conditions
#159METHODS OF ISOLATING CELLS FROM PLACENTAL TISSUE
#160METHODS FOR EXPANDING ADHERENT STROMAL CELLS AND CELLS OBTAINED THEREBY
#161ADHERENT STROMAL CELLS DERIVED FROM PLACENTAS OF MULTIPLE DONORS AND USES THEREOF
#162TISSUE-SPECIFIC DIFFERENTIATION MATRICES AND USES THEREOF
#163Stem cells and decellularization of tissue matrix from cord tissue
#164PLACENTA-DERIVED CELL-CONDITIONED MEDIUM FOR INDUCING DEDIFFERENTIATION INTO INDUCED PLURIPOTENT STEM CELLS FROM SOMATIC CELLS AND METHOD FOR INDUCING DEDIFFERENTIATION USING THE SAME
#165Method of targeting exosomes
#166FOETAL POLYMIX OF MESENCHYMAL STEM CELLS UNDER HYPOXIC CONDITIONS FOR THE TREATMENT OF CLINICAL DISORDERS AND DISEASES
#167Culture additive diffusion mechanism, culture container, culture system, and method of producing cells
#168METHOD FOR ISOLATING STEM CELLS FROM HUMAN UMBILICAL CORD
#169EXTRACELLULAR MATRIX COMPOSITION BEADS FOR CELL CULTURE
#170Protein engineered extracellular vesicles
#171Treatment of inflammatory diseases using placental stem cells
#172PRODUCTION OF THERAPEUTICS POTENTIAL MESENCHYMAL STEM CELLS
#173ISOLATION, CULTIVATION AND USES OF STEM/PROGENITOR CELLS
#174Placental lipid bilayer for cell-free molecular interaction studies
#175CELL POTENCY ASSAY
#176Acellular biologic composition and method of manufacture
#177Precursory regulatory cytotrophoblast cells and uses thereof
#178Compositions containing amniotic components and methods for preparation and use thereof
#179SYSTEMS AND METHODS TO DETECT STEM CELL STRESS AND USES THEREOF
#180MESENCHYMAL STROMAL CELLS AND METHODS FOR OBTAINING MESENCHYMAL STROMAL CELLS FROM UMBILICAL CORD
#181Human trophoblast stem cells and uses thereof
#182NATIVE WHARTON'S JELLY STEM CELLS AND THEIR PURIFICATION
#183Methods of manufacture of immunocompatible chorionic membrane products
#184METHOD OF INDUCING OR IMPROVING WOUND HEALING PROPERTIES OF MESENCHYMAL STEM CELLS
#185METHODS FOR TREATING RADIATION OR CHEMICAL INJURY
#186ADHERENT CELLS FROM PLACENTA AND USE OF SAME IN DISEASE TREATMENT
#187METHOD FOR OBTAINING A COMPOSITION CONTAINING A SPECIFIC POPULATION OF UMBILICAL CORD MESENCHYMAL CELLS AND USES THEREOF
#188Methods of manufacture of immunocompatible amniotic membrane products
#189Methods of Genomic Evaluation in Livestock
#190Multi-Chimeric Cell and Therapy for Transplantation and Treatment of Immune Deficiencies and Genetic Disorders
#191Method for enhancing expression of insulin like growth factor 1 receptor in mesenchymal stem cell, method for obtaining mesenchymal stem cell, and method for treating brain tissue damage
#192METHODS AND COMPOSITIONS FOR TREATING NEUROLOGICAL DISORDERS
#193Compositions of functional mitochondria and uses thereof
#194Acellular placental preparations
#195Methods of manufacture of therapeutic products comprising vitalized placental dispersions
#196STEM CELL COMPOSITIONS AND METHODS OF PRODUCING STEM CELLS FOR THERAPEUTIC APPLICATIONS
#197METHOD FOR REMOVAL OF YOLK
#198Artificial placenta and methods of preparation
#199Renovation and Repopulation of Decellularized Tissues and Cadaveric Organs by Stem Cells
#200METHODS FOR COLLECTING AND USING PLACENTA CORD BLOOD STEM CELLS
#201Composition derived from mammalian umbilical cord and Whartons jelly for use in therapeutic and regenerative applications
#202CELL SORTING METHOD AND SYSTEM
#203Human homogeneous amniotic fluid stem cell lines and uses thereof
#204FORMULATION COMPRISING EXTRACELLULAR VESICLES, METHOD FOR PRODUCING THE SAME, AND USES THEREOF
#205COMPOSITIONS AND METHODS FOR REPROGRAMMING CELLS AND FOR SOMATIC CELL NUCLEAR TRANSFER USING DUXC EXPRESSION
#206Immunocompatible amniotic membrane products
#207CD34+,CD45- PLACENTAL STEM CELL-ENRICHED CELL POPULATIONS
#208CELL EXPRESSION SYSTEM
#209METHOD AND MATERIAL FOR DIFFERENTIATED SEQUESTRATION OF SUBSTANCES OF DIFFERENT SUBSTANCE GROUPS WITH THE AID OF HYDROGELS CONTAINING SULPHATED OR SULPHONATED COMPONENTS
#210Isolation of cells from hatched reptile eggs for use in production of bioartificial skin and leather
#211Cell population comprising adherent cells derived from fetal appendage, method for producing the same, and pharmaceutical composition
#212Treatment of pain using placental stem cells
#213METHOD FOR PREPARING A SUPPLEMENT FROM MESENCHYMAL CELL CULTURES OF WHARTON'S JELLY AND USES OF SAME
#214Immunocompatible chorionic membrane products
#215COMPOSITION FOR COLLECTING AND PRESERVING PLACENTAL STEM CELLS AND METHODS OF USING THE COMPOSITION
#216FROZEN THERAPEUTIC DOSE AND PACKAGE
#217Method for producing amniotic mesenchymal stromal cell composition, method for cryopreserving the same, and therapeutic agent
#218ENHANCED HETATOPOIETIC STEM CELL TRANSPLANTATION
#219Methods of Genomic Evaluation in Livestock
#220Development of amnion-like tissue from human pluripotent stem cells
#221TREATMENT OF LYMPHEDEMA AND RELATED CONDITIONS USING PLACENTAL ADHERENT CELLS
#222PLACENTAL MESENCHYMAL STEM CELLS, METHODS OF PRODUCTION, AND PLACENTAL MESENCHYMAL STEM CELL BASED THERAPEUTICS
#223CULTIVATION OF PLACENTA TO ISOLATE EXOSOMES
#224Compositions containing amniotic components and methods for preparation and use thereof
#225Isolation, cultivation and uses of stem/progenitor cells
#226Method for preparing collagen having regeneration and repair effects from Wharton's Jelly mesenchymal stem cells
#227Cell population comprising mesenchymal stem cells derived from fetal appendage, method for producing the same, and pharmaceutical composition
#228METHODS AND COMPOSITIONS FOR TREATMENT OF BONE DEFECTS WITH PLACENTAL CELL POPULATIONS
#229Preparation of artificial tissues by means of tissue engineering using fibrin and agarose biomaterials
#230Transcription factors controlling differentiation of stem cells
#231Methods and Compositions for the Clinical Derivation of an Allogenic Cell and Therapeutic Uses
#232Methods of differentiating stem cells by modulating MIR-124
#233MEDIUM FOR CULTURING STEM CELLS, METHOD FOR CULTURING STEM CELLS, GROWTH PROMOTER FOR STEM CELLS, AND CELL COMPOSITION AND METHOD FOR PRODUCING SAME
#234Postpartum cells derived from placental tissue, and methods of making and using the same
#235Device for isolating stem cells from fetal tissues
#236Stem cells derived from pure chorionic trophoblast layer and cell therapy comprising same
#237Selection of Donors for Generation of Anti-Angiogenic Vaccine Compositions Including ValloVax
#238POPULATION OF AMNIOCYTES HAVING PHAGOCYTIC ACTIVITY AGAINST PATHOLOGICAL CELLS, PROCESS FOR THE PREPARATION THEREOF AND USES THEREOF IN THE MEDICAL FIELD
#239Composition for treating chronic pulmonary disease, comprising exosome derived from thrombin-treated stem cell
#240Method of isolating cells for therapy and prophylaxis
#241MESENCHYMAL STEM CELL THERAPY FOR SPINAL MUSCULAR ATROPHY
#242Tissue-derived tissuegenic implants, and methods of fabricating and using same
#243Compositions of functional mitochondria and uses thereof
#244STEM CELL COMPOSITIONS AND METHODS OF PRODUCING STEM CELLS FOR THERAPEUTIC APPLICATIONS
#245Selection Method Of Highly Active Stem Cell For Treatment Of Intraventricular Hemorrhage In Preterm Infant
#246Use of Neuropilin-1 (NRP1) as a cell surface marker for isolating human cardiac ventricular progenitor cells
#247Placenta-derived multipotent stem cells
#248Obtaining multipotent amnion-derived stem cell (ADSC) from amniotic membrane tissue without enzymatic digestion
#249Treatment of Glioma by Amniotic Fluid Stem Cells and Exosomes Derived Thereof
#250METHODS AND COMPOSITIONS FOR DETACHING ADHERENT CELLS
#251Placental tissue composition for for treating cardiac tissue damage
#252Formulation comprising extracellular vesicles, method for producing the same, and uses thereof
#253SYSTEMS AND METHODS TO DETECT STEM CELL STRESS AND USES THEREOF
#254METHOD FOR SEPARATING AND EXTRACTING HUC-MSC FROM WHARTON'S JELLY TISSUE OF UMBILICAL CORD
#255METHOD FOR PRODUCING CELL POPULATION COMPRISING MESENCHYMAL STEM CELLS, MESENCHYMAL STEM CELLS, CELL POPULATION, AND PHARMACEUTICAL COMPOSITION
#256Methods of manufacture of therapeutic products comprising vitalized placental dispersions
#257METHODS OF OBTAINING CELLS FROM HUMAN POSTPARTUM UMBILICAL CORD ARTERIAL TISSUE
#258Generation of autologous immune modulatory cells for treatment of neurological conditions
#259Soft tissue repair and regeneration using postpartum-derived cells and cell products
#260TREATMENT OF RETINAL DEGENERATION USING PROGENITOR CELLS
#261Products derived from amniotic fluid and methods of use
#262ANGIOGENESIS USING STIMULATED PLACENTAL STEM CELLS
#263Compositions derived from placenta and methods of producing the same
#264Stem cell packaging and shipping
#265Lithium stimulation of cord blood stem cell proliferation and growth factor production
#266Placental niche and use thereof to culture stem cells
#267STEM CELL-DERIVED OLIGODENDROCYTE PROGENITOR CELLS FOR THE TREATMENT OF WHITE MATTER STROKE
#268SYSTEMS AND METHODS FOR PROVIDING A STEM CELL BANK
#269Human trophoblast stem cells and uses thereof
#270Acellular biologic composition and method of manufacture
#271CELL TISSUE GEL CONTAINING COLLAGEN AND HYALURONAN
#272In vitro production of expanded potential stem cells
#273CELL EXPRESSION SYSTEM
#274Induced extended pluripotent stem cells, method of making and using
#275Placenta-derived matrix and methods of preparing and use thereof
#276EXOSOME COMPOSITIONS AND METHODS FOR PREPARATION AND USE THEREOF FOR REGULATING AND CONDITIONING SKIN AND HAIR
#277Method for obtaining sterile human amniotic fluid and uses thereof
#278TREATMENT OF PAIN USING PLACENTAL STEM CELLS
#279Isolation and cultivation of stem/progenitor cells from the amniotic membrane of umbilical cord and uses of cells differentiated therefrom
#280Method of progenitor cell isolation from different organs by natural destruction of extracellular matrix
#281Postnatal adherent cells and preparation method therefor
#282Immunotherapy of Cancer by Induction of Immunologically-Mediated Selective Killing of Tumor Vasculature Using Modified Endothelial Cells and Progenitors Thereof
#283Decellularized human amniotic membrane for cell delivery, cell culture and inflammation prevention
#284ANGIOGENESIS USING PLACENTAL STEM CELLS
#285INDUCING AND ACCELERATING POST-STROKE RECOVERY BY ADMINISTRATION OF AMNIOTIC FLUID DERIVED STEM CELLS
#286COMPOSITION DERIVED FROM MAMMALIAN UMBILICAL CORD AND WHARTONS JELLY FOR USE IN THERAPEUTIC AND REGENERATIVE APPLICATIONS
#287USE OF ADHERENT STROMAL CELLS FOR ENHANCING HEMATOPOIESIS IN A SUBJECT IN NEED THEREOF
#288Isolation, cultivation and uses of stem/progenitor cells
#289Methods for treating radiation or chemical injury
#290Human blood brain barrier model
#291Pharmaceutical composition for the prevention or treatment of a pulmonary disorder comprising mesenchymal stem cells having improved proliferation and differentiation capacity
#292Cell-based composition and use thereof for treatment of vernal keratoconjunctivitis
#293Stem cells and decellularized tissue matrix from cord tissue
#294Composition for collecting and preserving placental stem cells and methods of using the composition
#295Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
#296SYSTEMS AND METHODS TO DETECT STEM CELL STRESS AND USES THEREOF
#297Methods of genomic evaluation in livestock
#298IMPROVEMENTS IN TISSUE PROCESSING
#299Devices and methods for umbilical cord processing
#300PLACENTA-DERIVED ADHERENT CELL EXOSOMES AND USES THEREOF